BioCryst Pharma (BCRX) PT Lowered to $21 at JMP Securities, Following Earnings
Tweet Send to a Friend
JMP Securities analyst Jonathan Wolleben lowered the price target on BioCryst Pharma (NASDAQ: BCRX) to $21.00 (from $23.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
